- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Japanese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
4974 | JP¥1,050.00 | 6.0% | -16.1% | JP¥126.4b | JP¥1,466.67 | PE139.1x | E26.0% | 1.6% | ||
4880 | JP¥832.00 | 0.5% | -34.9% | JP¥16.5b | JP¥910.00 | PE69.5x | E23.9% | 0.6% |
Page 1 of 1